Literature DB >> 15609235

Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.

Julio C González1, William W Kwok, Anna Wald, Christopher L McClurkan, Jay Huang, David M Koelle.   

Abstract

Virus-specific memory T lymphocytes traffic to sites of viral infection. Herpes simplex virus (HSV) type 2-specific CD4(+) and CD8(+) T lymphocytes differ with regard to their homing kinetics to infected tissues. We studied the expression of cutaneous lymphocyte-associated antigen (CLA) and E-selectin ligand (ESL) by HSV-2-specific CD4(+) T lymphocytes. Virus-reactive T lymphocytes were identified ex vivo by CD154 or interferon-gamma up-regulation. We detected selective expression of CLA by HSV-2-reactive CD4(+) T lymphocytes, but at levels lower than those we previously observed for CD8(+) T lymphocytes. Short-term HSV-2-reactive CD4(+) lines generated from peripheral-blood mononuclear cells preferentially express CLA, compared with cytomegalovirus- or influenza-specific cells. CLA is expressed by HSV-2-reactive cells that are initially CLA negative before restimulation. Short-term culture-expanded HSV-2-specific CD4(+) T lymphocytes also selectively express ESL. These findings have implications for the optimization of vaccines for HSV and other cutaneous pathogens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15609235      PMCID: PMC1255909          DOI: 10.1086/426944

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  66 in total

1.  Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.

Authors:  David M Koelle; Zhi Liu; Christopher L McClurkan; Randal C Cevallos; Jeffrey Vieira; Nancy A Hosken; Clement A Meseda; Devon C Snow; Anna Wald; Lawrence Corey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

2.  CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions.

Authors:  Susmit Suvas; Ahmet Kursat Azkur; Bum Seok Kim; Uday Kumaraguru; Barry T Rouse
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

3.  Vesicular and pustular eruption related to cytomegalovirus in an immunocompetent patient.

Authors:  T Oskay; A Karademir; L Kutluay
Journal:  Clin Exp Dermatol       Date:  2003-11       Impact factor: 3.470

4.  Evolution of recurrent herpes simplex lesions. An immunohistologic study.

Authors:  A L Cunningham; R R Turner; A C Miller; M F Para; T C Merigan
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

5.  High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452.

Authors:  A M Duijvestijn; E Horst; S T Pals; B N Rouse; A C Steere; L J Picker; C J Meijer; E C Butcher
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

6.  Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals.

Authors:  Andrea Cavani; Francesca Nasorri; Chiara Ottaviani; Silvia Sebastiani; Ornella De Pità; Giampiero Girolomoni
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

7.  In vitro differentiation from naive to mature E-selectin binding CD4 T cells: acquisition of skin-homing properties occurs independently of cutaneous lymphocyte antigen expression.

Authors:  Ryo Takahashi; Yoshiko Mizukawa; Yoshimi Yamazaki; Kazuhito Hayakawa; Jun Hayakawa; Akihiko Kudo; Tetsuo Shiohara
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

8.  Pathogen-specific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients.

Authors:  Carlos S Subauste; Matthew Wessendarp; Jose-Andres C Portilllo; Rosa M Andrade; Linda M Hinds; Francisco J Gomez; A George Smulian; Peter A Grubbs; Lisa A Haglund
Journal:  J Infect Dis       Date:  2003-12-23       Impact factor: 5.226

9.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

10.  Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene.

Authors:  S Kit; M Kit; H Qavi; D Trkula; H Otsuka
Journal:  Biochim Biophys Acta       Date:  1983-11-17
View more
  13 in total

1.  Longitudinal analysis of herpes simplex virus-specific CD4+ cell clonotypes in infected tissues and blood.

Authors:  Serge Barcy; Meei-Li Huang; Lawrence Corey; David M Koelle
Journal:  J Infect Dis       Date:  2005-05-12       Impact factor: 5.226

2.  Varied levels of reactivity by different E-selectin/Fc constructs with cutaneous lymphocyte-associated antigen (CLA)(+) CD4(+) T cells.

Authors:  Zhenya Ni; Bruce Walcheck
Journal:  Immunol Lett       Date:  2007-01-03       Impact factor: 3.685

3.  Innate immune responses to herpes simplex virus type 2 influence skin homing molecule expression by memory CD4+ lymphocytes.

Authors:  David M Koelle; Jay Huang; Michael T Hensel; Christopher L McClurkan
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Homing in on the cellular immune response to HSV-2 in humans.

Authors:  David M Koelle; Julio C Gonzalez; Andrew S Johnson
Journal:  Am J Reprod Immunol       Date:  2005-04       Impact factor: 3.886

5.  A case of Ramsay Hunt-like syndrome caused by herpes simplex virus type 2.

Authors:  George A Diaz; Robert M Rakita; David M Koelle
Journal:  Clin Infect Dis       Date:  2005-04-13       Impact factor: 9.079

6.  Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.

Authors:  Nicholas J Moss; Amalia Magaret; Kerry J Laing; Angela Shaulov Kask; Minna Wang; Karen E Mark; Joshua T Schiffer; Anna Wald; David M Koelle
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 7.  Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity.

Authors:  D R Kaufman; D H Barouch
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.

Authors:  Lichen Jing; D Huw Davies; Tiana M Chong; Sookhee Chun; Christopher L McClurkan; Jay Huang; Brian T Story; Douglas M Molina; Siddiqua Hirst; Philip L Felgner; David M Koelle
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

9.  Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.

Authors:  Min Kim; Janette Taylor; John Sidney; Zorka Mikloska; Neil Bodsworth; Katerina Lagios; Heather Dunckley; Karen Byth-Wilson; Martine Denis; Robert Finlayson; Rajiv Khanna; Alessandro Sette; Anthony L Cunningham
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 10.  T-cell immunity to human alphaherpesviruses.

Authors:  Werner J D Ouwendijk; Kerry J Laing; Georges M G M Verjans; David M Koelle
Journal:  Curr Opin Virol       Date:  2013-05-08       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.